ANI Pharmaceuticals' generic dexamethasone tablets get FDA approval

Aug. 16, 2022 7:10 AM ETANI Pharmaceuticals, Inc. (ANIP)By: Ravikash, SA News Editor

Headquarters of US Food and Drug Administration (FDA)

Grandbrothers/iStock Editorial via Getty Images

  • The U.S. Food and Drug Administration (FDA) approved ANI Pharmaceuticals' (NASDAQ:ANIP) generic dexamethasone tablets USP 1.5mg, 4mg and 6mg.
  • The company's dexamethasone tablets are the generic version of reference drug Decadron.
  • Dexamethasone is a type of corticosteroid used to treat several health conditions, which include skin conditions, allergies, swelling, and autoimmune conditions, among others.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.